WellBiotec Co EPS
The Earnings per Share (EPS) of WellBiotec Co (010600.KS) as of Nov 5, 2026 is -267.94 KRW. In the previous year, Earnings per Share (EPS) was -819.61 KRW — a change of -67.31% (higher).
Get this data via API
Financial Data API
EPS
-267.94KRW
YoY
-67.31%
Last updated:
The WellBiotec Co EPS history
3 Years
10 Years
25 Years
Max
| YEAR | EPS | YoY |
|---|---|---|
| -267.94KRW | -67.31% | |
| -819.61KRW | +152.48% | |
| -324.62KRW | -46.00% | |
| -601.19KRW | -60.77% | |
| -1,532.52KRW | +320.75% | |
| -364.24KRW | -53.20% | |
| -778.30KRW | +33.54% | |
| -582.80KRW | +256.82% | |
| -163.33KRW | -545.45% | |
| 36.67KRW | -107.71% | |
| -475.36KRW | -360.31% | |
| 182.62KRW | -174.39% | |
| -245.50KRW | -270.70% | |
| 143.82KRW | -113.35% | |
| -1,077.00KRW | -29.60% | |
| -1,529.86KRW | -83.41% | |
| -9,221.33KRW | +187.09% | |
| -3,212.00KRW | -508.65% | |
| 786.00KRW | +38.26% | |
| 568.50KRW | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
WellBiotec Co Stock analysis
Frequently Asked Questions about WellBiotec Co stock
Earnings per Share (EPS) of WellBiotec Co is -267.94 KRW in 2024.
Earnings per Share (EPS) of WellBiotec Co changed from -819.61 KRW to -267.94 KRW, representing a -67.31% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Earnings per Share (EPS) WellBiotec Co since 2006 – with annual values, charts, and detailed analysis.
Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.
EPS = Net Income / Shares Outstanding
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — WellBiotec Co
All Key Metrics — WellBiotec Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth